Literature DB >> 23413042

Comprehensive profiling of peripheral immune cells and subsets in patients with intermittent allergic rhinitis compared to healthy controls and after treatment with glucocorticoids.

Huan Zhang1, Lars Olaf Cardell, Janne Bjorkander, Mikael Benson, Hui Wang.   

Abstract

Intermittent allergic rhinitis (IAR) is a common allergic disease, which is associated with local infiltration of T cells, eosinophils, and basophils. However, changes of circulating inflammatory cells may reflect local and systemic allergic inflammation and potentially, also the response to treatment with glucocorticoids (GCs). In this study, we comprehensively profiled peripheral blood immune cells and subsets from 12 patients with IAR during the birch pollen season before and after GC treatment and nine healthy controls by flow cytometry. Orthogonal partial least squares discriminant analysis (OPLS-DA) identified that peripheral immune cells and subsets markedly separated symptomatic patients and controls. Eosinophils, basophils, and Th2 cells contributed most to the separation. However, there was no good separation between patients before and after GC treatment. Local allergic inflammation in the nasal mucosa is associated with increased circulating Th2 cells, eosinophils, and basophils. Local GC treatment has limited effects on circulating immune cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413042     DOI: 10.1007/s10753-013-9608-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  50 in total

1.  IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season.

Authors:  C Woschnagg; R Garcia; S Rak; P Venge
Journal:  Clin Exp Allergy       Date:  2001-04       Impact factor: 5.018

2.  Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.

Authors:  E M Erin; A S Zacharasiewicz; G C Nicholson; A J Tan; L A Higgins; T J Williams; R D Murdoch; S R Durham; P J Barnes; T T Hansel
Journal:  Clin Exp Allergy       Date:  2005-12       Impact factor: 5.018

3.  Systemic effects of allergen exposure on blood basophil IL-13 secretion and FcepsilonRIbeta.

Authors:  Sarbjit Saini; D Candy Bloom; Anja Bieneman; Kavitha Vasagar; Alkis Togias; John Schroeder
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

Review 4.  T-cell responses to allergens.

Authors:  Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

5.  The origins of basophils and eosinophils in allergic inflammation.

Authors:  J A Denburg
Journal:  J Allergy Clin Immunol       Date:  1998-11       Impact factor: 10.793

6.  Perception of lung function, adherence to inhaled corticosteroids, and the role of peak expiratory flow feedback in paediatric asthma.

Authors:  James Y Paton
Journal:  Thorax       Date:  2012-09-05       Impact factor: 9.139

7.  An essential role for dendritic cells in human and experimental allergic rhinitis.

Authors:  Alex KleinJan; Monique Willart; Leonie S van Rijt; Gert-Jan Braunstahl; Karolina Leman; Steffen Jung; Henk C Hoogsteden; Bart N Lambrecht
Journal:  J Allergy Clin Immunol       Date:  2006-08-28       Impact factor: 10.793

8.  Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.

Authors:  Fazil Orhan; Bulent Enis Sekerel; Gonul Adalioglu; Munevver Pinar; Ayfer Tuncer
Journal:  Ann Allergy Asthma Immunol       Date:  2004-04       Impact factor: 6.347

9.  Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

Authors:  K Masuyama; M R Jacobson; S Rak; Q Meng; R M Sudderick; A B Kay; O Lowhagen; Q Hamid; S R Durham
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

10.  Allergen immunotherapy in intermittent allergic rhinitis reduces the intracellular expression of IL-4 by CD8+ T cells.

Authors:  Joanna Glück; Barbara Rogala; Edmund Rogala; Ewa Oleś
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

View more
  5 in total

1.  Alterations on peripheral blood B cell subsets induced by allergic rhinitis.

Authors:  Ana Henriques; Rodrigo Nunes; Graça Loureiro; António Martinho; Maria Pais; António Segorbe-Luís; Hélder Trindade; Celso Pereira; Artur Paiva
Journal:  Inflamm Res       Date:  2015-02-21       Impact factor: 4.575

2.  DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structure.

Authors:  Colm E Nestor; Fredrik Barrenäs; Hui Wang; Antonio Lentini; Huan Zhang; Sören Bruhn; Rebecka Jörnsten; Michael A Langston; Gary Rogers; Mika Gustafsson; Mikael Benson
Journal:  PLoS Genet       Date:  2014-01-02       Impact factor: 5.917

Review 3.  The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis.

Authors:  Galateja Jordakieva; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2018-08-15       Impact factor: 4.084

4.  Reduced CD4+T Cell CXCR3 Expression in Patients With Allergic Rhinitis.

Authors:  Xiaofeng Yu; Meng Wang; Zhiwei Cao
Journal:  Front Immunol       Date:  2020-11-03       Impact factor: 7.561

5.  Allergic rhinitis, allergic contact dermatitis and disease comorbidity belong to separate entities with distinct composition of T-cell subsets, cytokines, immunoglobulins and autoantibodies.

Authors:  Wenjia Chai; Xuyi Zhang; Meixiong Lin; Zhuo Chen; Xiaolin Wang; Changqing Wang; Aoyan Chen; Caisheng Wang; Hongwu Wang; Honghong Yue; Jingang Gui
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-11       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.